Advocate Children's Hospital offers a family-centered, multidisciplinary approach to offer the latest advancements in diagnostic and treatment services to children with blood diseases and cancer. In the area of blood diseases (other than cancer), Advocate Children's Hospital provides cutting edge diagnostic and treatment options for pediatric hematological disorders including sickle cell disease, thrombocytopenia, hemophilia, von Willebrand Disease, coagulapathies, hemoglobinopathies, leukopenia, neutropenia and all anemias. In addition, Advocate Children's Hospital - Oak Lawn has recently established a comprehensive Sickle Cell Clinic and is participating in a national sickle cell disease registry.
In the area of pediatric cancer, Advocate Children's Hospital is a member of the Children's Oncology Group (COG) clinical trials network. COG grew out of several cooperative research groups established by the National Cancer Institute in 1955. COG coordinates cancer clinical trials at 238 member institutions, including cancer centers of all major universities and teaching hospitals. By treating children in clinical trials, COG members have increased the cancer cure rate for children from less than 10 percent in the 1950s to nearly 80 percent at present, in COG member hospitals. Over half of all children in the United States with cancer are enrolled in a clinical trial.
A significant number of clinical trials are open and ongoing at Advocate Children's Hospital to offer children with cancer and other conditions with access to the newest types of treatments and diagnostic methods. We are currently enrolling children in clinical trials with the following types of cancers: acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin's disease, Non-Hodgkins disease, renal (kidney) tumors, Wilm's tumor, neuroblastoma, lymphoma, rhabdomyosarcoma, Ewing's sarcoma, hepatoblastoma, brain tumors, and medulloblastoma. Patients are seen in both our regular oncology clinic and in our long-term survivor clinic. If you are interested in additional information on these clinical trials, please contact, for Advocate Children's Hospital - Oak Lawn, Jane Suszek, Clinical Research Associate, at 708.684.4384, email@example.com.; for Advocate Children's Hospital - Park Ridge, Rina DiMaso, Clinical Research Associate, at 847.723.9472, firstname.lastname@example.org.
Click below to view the current pediatric hematology and oncology studies:
For COG studies, contact one of the Clinical Research Associates above for more information.